Scientists with Medicinal Genomics have sequenced the Cannabis sativa genome:
[Medicinal Genomics founder Kevin McKernan] says he was turned on to the idea of sequencing cannabis by a 2003 publication in Nature Reviews Cancer about the many potential uses – including fighting cancer – of cannabinoids. C. sativa makes about sixty of the compounds. Although THC has gotten the most attention, McKernan hopes his company’s data will help scientists explore a few of the others, and perhaps guide plant breeding programs to generate new Cannabis strains. … Also appealing to McKernan: the growing medical marijuana market, which he says is swelling by over 50% a year. “It’s going to have to be a fairly regulated market,” he says, “and regulation is going to come through genetics and fingerprinting of which strains are approved.”
(Photo: A worker packs cannabis at the growing facility of the Tikun Olam company on March 7, 2011 near the northern city of Safed, Israel. In conjunction with Israel's Health Ministry, Tikon Olam are currently distributing cannabis for medicinal purposes to over 1800 people in Israel. By Uriel Sinai/Getty Images)
The Dish 